merged_ftc-pharmacy-benefit-managers-drug-prices.txt


<question_number>1</question_number>
<answer>N/A</answer>
<question_number>2</question_number>
<answer>N/A</answer>
<question_number>3</question_number>
<answer>N/A</answer>
<other>The text does not provide specific information to answer any of the questions directly. The FTC has not brought a lawsuit, the acquisition year of Caremark by CVS Health is not mentioned, and the $1.6 billion figure refers to revenue, not patient overpayment.</other>